CMS and CDC Issue Final Rulemaking Updating CLIA Fees
CMS and the CDC issued Final Rulemaking [CMS-3326-F] to update the CLIA fees and clarify the CLIA fee regulations.
Read MorePosted by Chris Wolski | Jan 5, 2024 | Compliance |
CMS and the CDC issued Final Rulemaking [CMS-3326-F] to update the CLIA fees and clarify the CLIA fee regulations.
Read MorePosted by Andy Lundin | Jan 2, 2024 | Standards |
The Matrix Plus Chemistry Reference Kit and the stand-alone, ultra-high Matrix Plus Chemistry Reference – Level F are now available.
Read MorePosted by Andy Lundin | Dec 27, 2023 | Dementias & Alzheimer’s, Immunoassay Reagents & test Kits |
These reagents, the HISCL β-Amyloid 1-42 and 1-40 assay kits, have attained CE-IVD marking as of May 17, 2022.
Read MorePosted by Andy Lundin | Dec 19, 2023 | Urinalysis & Toxicology |
The new panel from Quest tests for 88 compounds, and covers a broad array of drug classes, and other illicit additives.
Read MorePosted by Chris Wolski | Dec 6, 2023 | Calibrators |
Kits are available from Verichem Laboratories for the calibration verification testing of both urine and serum magnesium assays.
Read More